Blog
Pharmaceutical and API manufacturing clearances in Haryana: HSPCB, EIA, factory licence, and fire NOC for drug plants
Niche guide for pharma, API, formulation, and biotech units in Haryana. Red-category HSPCB consent, SEIAA environmental clearance, factory plan approval, solvent-storage fire NOC, building plan sanction, biomedical waste authorisation, and occupation certificate—before drug manufacturing licence filing.
Industrial, commercial, and residential project capacity. Not for personal or small individual requests.
Sep 2026 · Pharmaceutical · Haryana, Ambala, Panchkula
Key takeaways
- Pharmaceutical and API plants in Haryana almost always fall under HSPCB red or orange pollution categories because of solvent use, effluent, and emissions—consent to establish and operate is non-negotiable before commissioning.
- Many API and bulk drug projects trigger prior environmental clearance through SEIAA, Haryana under the EIA Notification; HSPCB CTE is typically processed only after EC where applicable.
- Statutory clearances (EIA, HSPCB, factory plan, factory licence, fire NOC, building plan, CEI, OC) are separate from but prerequisite to state drug manufacturing licence under Drugs & Cosmetics Rules—a common sequencing mistake.
- Solvent storage, hazardous chemical handling, and effluent treatment plant design must align across factory plan, fire schematic, HSPCB application, and building sanction before equipment import.
Who this pharma clearance guide is for
This guide targets promoters setting up API (active pharmaceutical ingredient) plants, formulation units, nutraceutical manufacturing, contract manufacturing organisations (CMOs), and biotech processing facilities in Haryana at industrial project scale. It covers statutory clearances—environmental, pollution, factory, fire, electrical, and building approvals—that Acreage Approval Corp coordinates before and alongside drug manufacturing licence applications. It does not replace State Drug Controller or CDSCO licensing advice. We do not handle personal or small individual requests.
Why pharmaceutical plants face heavier clearance scrutiny
Pharma manufacturing generates solvent emissions, process effluent, hazardous waste, and often requires dedicated effluent treatment plants (ETP), solvent recovery, and air pollution control systems. HSPCB typically classifies API and formulation units in red or orange categories with continuous monitoring obligations. EIA Notification lists pharmaceutical intermediates, bulk drugs, and formulation projects above capacity thresholds for prior environmental clearance. Factory plan approval reviews chemical storage, ventilation, exits, and machinery layout under the Factories Act. Fire departments scrutinize solvent tank farms, flammable storage, and assembly occupancies. A generic industrial shed clearance checklist misses pharma-specific dependencies—promoters discover this after ordering imported reactors.
Step 1: Site selection for pharma units in Haryana
Haryana's pharmaceutical investment clusters include Ambala and Yamunanagar (API and formulation belt), Panchkula and adjoining zones, Faridabad and Manesar industrial areas, and Panipat chemical-pharma adjacency. Before land purchase, confirm industrial land use, distance from residential zones, estate bylaws on hazardous storage, and whether SEIAA or local authority restricts pharma categories in that pocket. Plots lacking lawful industrial zoning or adequate buffer from habitation fail EC and HSPCB scrutiny regardless of building design quality. Review notified industrial estate allotments (HSIIDC, municipal industrial plots) for pre-approved utilities and access roads for hazardous material transport.
Step 2: Environmental clearance for API and bulk drug projects
Determine EIA Notification applicability from product category, production capacity, and schedule listing. Category B pharma projects in Haryana are appraised by SEIAA, Haryana; sensitive or very large projects may route centrally. The process includes Form 1, Terms of Reference (TOR), EIA report, public consultation where mandated, and SEIAA clearance with conditions on effluent quality, emissions, and waste disposal. Environmental clearance is an upstream gate—starting civil works or ordering equipment before EC exposes promoters to stop-work orders and complicates later HSPCB consent. API plants with solvent-intensive processes should budget several months for EC alone.
Step 3: HSPCB consent for pharmaceutical manufacturing
Haryana State Pollution Control Board issues consent to establish (CTE) before commissioning pollution control equipment and consent to operate (CTO) before full production. Pharma applications require detailed process descriptions, material balance, solvent lists, ETP and scrubber design, stack parameters, hazardous waste management plan, and groundwater usage disclosures where applicable. Red category units face stricter inspection and online continuous monitoring requirements. CTE renewal, capacity expansion, and additional product lines need amendment filings—not silent continuation. HSPCB consent conditions must match factory plan and building plan submissions; inconsistencies between drawings and pollution applications cause rejection cycles in Gurgaon and Faridabad belts.
Step 4: Factory plan approval and factory licence
The Chief Inspector of Factories, Haryana reviews factory plan approval for layout of reactors, solvent storage, ETP areas, exits, ventilation, and hazardous process zones before construction completes. Factory licence authorises manufacturing operation after plan compliance verification. Pharma units with chemical processing typically require plan approval even when building shell appears as a standard industrial shed. Principal employer registration applies when construction contractors supply labour. Factory plan must reflect fire access, HSPCB conditions, and building sanction dimensions—three-way alignment prevents licence inspection failures at pre-commissioning stage.
Step 5: Building plan, fire NOC, and solvent storage compliance
Pharma plants require building plan sanction through OBPAS and competent authority (HSIIDC, DTCP, or municipal corporation). Drawings must show ETP rooms, solvent storage bund walls, hazardous material stores, admin blocks, and laboratory areas with correct occupancy classifications. Fire schematic approval reviews hydrants, foam systems, sprinkler coverage for production blocks, and tender access for solvent unloading. Final fire NOC follows installation testing. Solvent storage above threshold quantities triggers additional hazardous occupancy scrutiny. Coordinate fire consultant sign-off with HSPCB hazardous waste and storage disclosures before first portal submission.
Step 6: Electrical load, CEI, and utility energisation
API and formulation plants draw significant connected load for HVAC, reactors, chillers, and clean utility systems. Discom load sanction and Chief Electrical Inspector (CEI) approval must match sanctioned drawings and actual HT/LT installation. Energisation before valid CEI clearance blocks commissioning and drug licence inspection readiness. Plan substation and DG set locations on building and factory plans early—retrofit after civil completion is costly in regulated pharma builds.
Biomedical waste, drug licence, and parallel regulatory tracks
Pharmaceutical operations generate biomedical waste governed by BMW Rules—authorization from Haryana pollution board or designated authority is required alongside HSPCB consent. Drug manufacturing licence under Drugs & Cosmetics Rules (state manufacturing licence for most units; CDSCO for specified categories) is a separate regulatory track managed by State Drug Controller. Inspectors expect statutory clearances—valid HSPCB CTO, factory licence, fire NOC, building OC—to be in place before GMP inspection. Sequencing error: completing GMP fit-out before pollution or factory certificates delays commercial batch release by quarters.
Commissioning checklist before pharma plant go-live
Before first commercial batch: secure HSPCB consent to operate after ETP commissioning tests; factory licence after pre-commissioning inspection; final fire NOC; CEI energisation clearance; occupation certificate from building authority; BMW authorization active; environmental clearance compliance report filed if SEIAA conditions require post-construction verification. Drug manufacturing licence and WHO-GMP inspection follow statutory clearance completion. Promoters who treat pollution and factory certificates as post-GMP tasks lose launch timelines and anchor client audits.
Contact for pharmaceutical project clearance planning
Acreage Approval Corp maps the statutory clearance chain for API, formulation, and biotech manufacturing projects across Haryana—EIA, HSPCB, factory plan and licence, building plan compliance, fire NOC, CEI, and occupation certificate. Share product category, capacity, solvent/effluent profile, plot location, and target commissioning date. Set up a call, WhatsApp, or [email protected]. We do not handle personal or small individual requests.
Frequently asked questions
Typical API and formulation plants need SEIAA environmental clearance (if listed), HSPCB consent to establish and operate, factory plan approval, factory licence, building plan sanction, fire schematic and fire NOC, electrical load sanction and CEI approval, BOCW during construction, biomedical waste authorization, and occupation certificate—before state drug manufacturing licence application.